New Approaches to Smoking Cessation in Heavy Drinkers
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop and test an integrated cognitive-behavioral
intervention for smoking and alcohol among heavy drinking smokers. The current pre-pilot
phase will be used to refine this protocol for the subsequent randomized, controlled pilot
phase. The current study phase has two parts: 1) an intake session and brief physical; 2) a
12-week treatment phase in which participants receive varenicline (Chantix) and weekly,
personalized counseling.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)